Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Short-term exposure to low levels of air pollution can affect gene expression

New data from a landmark study by Monash University researchers raises concerns that even short-term exposure to low level air pollution can affect gene expression, leaving us at risk of diseases such as cancer, cardiovascular and respiratory diseases.

25 Jun 2020

Herd immunity could be achieved with less people being infected, study says

Herd immunity to Covid-19 could be achieved with less people being infected than previously estimated according to new research.

24 Jun 2020

University of Kentucky collaborates with Atomwise to explore potential COVID-19 therapies

The University of Kentucky announced a research collaboration with Atomwise, an industry leader in using artificial intelligence (AI) for small molecule discovery, to explore potential COVID-19 therapies.

24 Jun 2020

White Paper: Separation and characterization of viruses and antibodies

Postnova Analytics have published an informative new white paper that details how multi-detector Asymmetrical Field Flow Fractionation (AF4) and Electrical AF4 (EAF4) techniques are transforming the separation and characterization of viruses and antibodies.

From Postnova Analytics 23 Jun 2020

COVID-19 Lockdown Reveals Human Impact On Wildlife

Leaders explain how research during this devastating health crisis can inspire innovative strategies for sharing space on this increasingly crowded planet.

23 Jun 2020

Study shows MMR vaccine may protect against COVID-19 symptoms

According to a group of experts, the administration of the MMR vaccine could act as a preventive measure to reduce inflammation linked to COVID-19 infection.

22 Jun 2020

Increased Power from Solar Panels Thanks to COVID-19

During the COVID-19 pandemic, one unexpected outcome in cities around the world has been a reduction in air pollution, as people stay home to avoid contracting the coronavirus.

22 Jun 2020

Coronavirus: A Wake-Up Call To Strengthen The Global Food System

Global food production is incredibly efficient, and the world's farmers produce enough to feed the global population.

22 Jun 2020

‘Cultured meat’ will prevent zoonotic diseases such as that which may have caused COVID-19

Meat alternatives that are already at an advanced stage of development could be the solution to the high socioeconomic impact of zoonotic diseases.

From Biotech Foods 19 Jun 2020

NJIT researchers develop new efficient method to quantify therapeutic proteins

Researchers at New Jersey Institute of Technology in collaboration with Ohio University and Merck & Co. Inc. recently developed a new efficient method for targeted protein analysis -- one they say could speed up processes for disease testing, drug discovery and vaccine development.

18 Jun 2020

Study shows how viruses evade antiviral defenses

According to a new study, researchers have identified a novel antiviral defense system that can possibly be used for treating several viral infections.

17 Jun 2020

Researchers identify antibody cocktail with potential to neutralize SARS-CoV-2 virus

Researchers at the University of Maryland School of Medicine evaluated several human antibodies to determine the most potent combination to be mixed in a cocktail and used as a promising anti-viral therapy against the virus that causes COVID-19.

17 Jun 2020

COVID-19 Antibody Tests: How Reliable Are They?

With stay-at-home orders expiring around the world, many hope that COVID-19 antibody testing will help businesses and institutions reopen safely.

17 Jun 2020

Combination drugs for COVID-19 show promise in laboratory tests

Six months into the COVID-19 pandemic, more than 7.4 million people have been infected, and more than 410 000 have died. As yet, there is no treatment or vaccine for the disease.

16 Jun 2020

BCG vaccine elicits trained immunity in humans

A tuberculosis vaccine developed 100 years ago also makes vaccinated persons less susceptible to other infections.

16 Jun 2020

Potent human antibodies protect against SARS-CoV-2 in animal tests

A team led by Scripps Research has discovered antibodies in the blood of recovered COVID-19 patients that provide powerful protection against SARS-CoV-2, the coronavirus that causes the disease, when tested in animals and human cell cultures.

16 Jun 2020

Interconnected mycobacteria stay alive longer

The tuberculosis pathogen Mycobacterium tuberculosis can protect itself better when combined and thus stay alive longer in the air.

15 Jun 2020

Coronavirus (COVID-19) sample tracking packages

To assist labs involved with the essential RT-PCR assay part of the “test, trace and isolate” strategy for dealing with the SARS-CoV-2 virus pandemic – Ziath has introduced two optimized packages for reliable tracking of patient samples submitted for Coronavirus (COVID-19) testing.

From Ziath Ltd 10 Jun 2020

Study shows how a fat cell's immune response exacerbates obesity

When obesity occurs, a person's own fat cells can set off a complex inflammatory chain reaction that can further disrupt metabolism and weaken immune response--potentially placing people at higher risk of poor outcomes from a variety of diseases and infections, including COVID-19.

8 Jun 2020

Scientists aim to develop a gene-targeting, antiviral agent to combat COVID-19

A team of scientists from Stanford University is working with researchers at the Molecular Foundry, a nanoscience user facility located at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab), to develop a gene-targeting, antiviral agent against COVID-19.

5 Jun 2020